Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 17.50
  • 52 Week Low: 5.75
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 127,318
  • Market Cap: £22.44m
  • RiskGrade: 429

Verici granted 'fundamental' codes for tests in US market

By Josh White

Date: Tuesday 04 Jan 2022

LONDON (ShareCast) - (Sharecast News) - Organ transplant diagnostics company Verici Dx has been granted 'CPT' proprietary laboratory analyses (PLA) codes for both its 'Clarava' and 'Tuteva' tests by the American Medical Association (AMA), it announced on Tuesday.
The AIM-traded firm said the new codes were approved and published by the AMA Editorial Panel, and were scheduled to become effective on 1 April.

It explained that reimbursement in the United States medical market consisted of three components - code, price and coverage.

The company said CPT codes offered healthcare professionals a uniform language for coding medical services and procedures, with the CPT PLA code allowing laboratories to more specifically identify their tests when billing Medicare and commercial insurers.

Verici said the successful granting of a CPT code marked the first step on the path for commercial reimbursement.

"We were delighted with the AMA's decision, as CPT codes are fundamental in the commercialisation of our lead products," said executive vice-president of product development Patti Connolly.

At 1348 GMT, shares in Verici Dx were up 9.05% at 57.8p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 9.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 17.50
52 Week Low 5.75
Volume 127,318
Shares Issued 242.54m
Market Cap £22.44m
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.81% below the market average39.81% below the market average39.81% below the market average39.81% below the market average39.81% below the market average
37.04% below the sector average37.04% below the sector average37.04% below the sector average37.04% below the sector average37.04% below the sector average
Price Trend
46.4% below the market average46.4% below the market average46.4% below the market average46.4% below the market average46.4% below the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:28 102 @ 9.00p
16:03 3,447 @ 9.25p
15:41 50,000 @ 9.30p
15:09 30,000 @ 9.30p
15:08 10,000 @ 9.00p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page